Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Stassen

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1973
Cell-free synthesis of procollagen: L-929 fibroblasts as a cellular model for dermatosparaxisS S Kerwar, G J Cardinale, L D Kohn, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidneyF L Stassen, R W Erickson, W F Huffman, et al.
Molecular Pharmacology|March 1, 1987
A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926F L Stassen, G Heckman, D Schmidt, et al.
Biochemical Pharmacology|November 1, 1986
Induction of functional beta-adrenergic receptors in rat aortic smooth muscle cells by sodium butyrateP Nambi, M H Whitman, D B Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogsC R Albrightson-Winslow, N Caldwell, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta)D P Brooks, P F Koster, C R Albrightson-Winslow, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogsN Caldwell, B Brickson, L B Kinter, et al.
Molecular Pharmacology|February 1, 1988
Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cellsF L Stassen, G Heckman, D Schmidt, et al.
British Journal of Pharmacology|July 1, 1988
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkeyD P Brooks, P F Koster, F L Stassen, et al.
Progress in Brain Research|January 1, 1983
Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonistsF L Stassen, W Bryan, M Gross, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1973
Cell-free synthesis of procollagen: L-929 fibroblasts as a cellular model for dermatosparaxisS S Kerwar, G J Cardinale, L D Kohn, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1982
Molecular mechanisms of novel antidiuretic antagonists: analysis of the effects on vasopressin binding and adenylate cyclase activation in animal and human kidneyF L Stassen, R W Erickson, W F Huffman, et al.
Molecular Pharmacology|March 1, 1987
A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926F L Stassen, G Heckman, D Schmidt, et al.
Biochemical Pharmacology|November 1, 1986
Induction of functional beta-adrenergic receptors in rat aortic smooth muscle cells by sodium butyrateP Nambi, M H Whitman, D B Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1989
Cyclooxygenase inhibition unmasks the full antidiuretic agonist activity of the vasopressin antagonist, SK&F 101926, in dogsC R Albrightson-Winslow, N Caldwell, D P Brooks, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta)D P Brooks, P F Koster, C R Albrightson-Winslow, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogsN Caldwell, B Brickson, L B Kinter, et al.
Molecular Pharmacology|February 1, 1988
Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cellsF L Stassen, G Heckman, D Schmidt, et al.
British Journal of Pharmacology|July 1, 1988
Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkeyD P Brooks, P F Koster, F L Stassen, et al.
Progress in Brain Research|January 1, 1983
Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonistsF L Stassen, W Bryan, M Gross, et al.
Pageof 4